BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21692760)

  • 1. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients.
    Van Lancker P; Dillemans B; Bogaert T; Mulier JP; De Kock M; Haspeslagh M
    Anaesthesia; 2011 Aug; 66(8):721-5. PubMed ID: 21692760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of neuromuscular blockade by sugammadex in laparoscopic bariatric surgery: In support of dose reduction.
    Badaoui R; Cabaret A; Alami Y; Zogheib E; Popov I; Lorne E; Dupont H
    Anaesth Crit Care Pain Med; 2016 Feb; 35(1):25-29. PubMed ID: 26597732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
    Gaszynski T; Szewczyk T; Gaszynski W
    Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients.
    Loupec T; Frasca D; Rousseau N; Faure JP; Mimoz O; Debaene B
    Anaesthesia; 2016 Mar; 71(3):265-72. PubMed ID: 26685122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.
    Abd El-Rahman AM; Othman AH; El Sherif FA; Mostafa MF; Taha O
    Minerva Anestesiol; 2017 Feb; 83(2):138-144. PubMed ID: 27575450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients.
    Li D; Wang Y; Zhou Y; Yin C
    J Int Med Res; 2021 Jan; 49(1):300060520985679. PubMed ID: 33499679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
    Cammu G; Coart D; De Graeve K; Beelen R
    Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
    Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery.
    Llauradó S; Sabaté A; Ferreres E; Camprubí I; Cabrera A
    Anesthesiology; 2012 Jul; 117(1):93-8. PubMed ID: 22549697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
    Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
    Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
    McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
    Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.